CapsoVision (CV) vs Avita Medical (RCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Avita Medical (RCEL) has outperformed CapsoVision (CV) over the past year, gaining 138.6% versus a gain of 38.9%. Avita Medical is the larger company by market cap ($407.3 million vs $353.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | RCEL |
|---|---|---|
| Share price | $6.64 | $13.17 |
| Market cap | $353.32M | $407.31M |
| 1-day change | +1.53% | +0.92% |
| YTD return | -38.82% | +278.26% |
| 1-year return | +38.85% | +138.57% |
| 5-year return | — | -24.87% |
| EPS (TTM) | $-0.45 | $-1.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $13.50 |
| 52-week low | $4.38 | $3.22 |
| Distance from 52-week high | -56.80% | -2.44% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +43.07% | -8.66% |
| Average volume | 158.10K | 441.70K |
| Shares outstanding | 53.21M | 30.93M |
| Employees | 99 | 226 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed CV by 99.7 percentage points over the past year.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Health Care · Medical/Dental Instruments · 226 employees
CV vs RCEL FAQ
Which is bigger, CapsoVision or Avita Medical?
Avita Medical (RCEL) is larger, with a market capitalization of $407.31M compared with $353.32M for CapsoVision (CV).
Which stock has performed better over the past year, CV or RCEL?
RCEL returned +138.57% over the past 12 months, compared with +38.85% for CV (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Avita Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CapsoVision and Medical/Dental Instruments for Avita Medical.